oxycodone and semaglutide Medscape | The FDA has approved once-daily oral 25 mg (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. ⁠ Semaglutide | DirectMeds

Stillbirth rates are also slightly elevated at 0.6-1.0% compared to 0.4-0.6% in women without these conditions

As patients and clinicians explore these medications' broader metabolic impacts, questions arise about potential effects on cortisolthe stress hormone linked to central weight gain and insulin resistance

Side Effects and Ethical Concerns Long-term side effects (e.g., pancreatitis, thyroid tumors) could result in litigation or reduced prescriptions

Future research should prioritize longitudinal studies to assess changes in sexual desire among individuals prescribed GLP-1 agonists

Biomarkers and Genetic Context: Who May Benefit Most From Dual Therapy Before starting metformin and semaglutide together, understanding your metabolic baselineincluding fasting insulin, HOMA-IR (insulin resistance index), and fasting glucosehelps providers assess which agent may have the greatest impact